The simplest way to think about it Wegovy works on 1 pathway (GLP-1) Mounjaro works on 2 pathways (GLP-1 + GIP) Retatrutide (still being studied) works on 3 pathways (GLP-1 + GIP + glucagon) More pathways may mean stronger appetite and metabolic effects, which is why retatrutide is getting so much attention
Call 999 or go to A&E immediately if you experience: Severe difficulty breathing or stridor (a high-pitched sound when breathing) Severe swelling in the throat or neck Drooling or inability to swallow liquids Severe chest pain Contact your GP or NHS 111 if you experience: Severe or worsening throat pain that interferes with swallowing or speaking Difficulty swallowing (dysphagia) , particularly if progressive or associated with pain Persistent symptoms not improving after a week High fever (38C or above) accompanying throat symptoms Visible swelling in the neck or throat Blood in saliva or phlegm Hoarseness lasting more than 3 weeks Severe symptoms of reflux , including persistent heartburn, regurgitation, or chest pain Unintentional weight loss beyond your treatment goals, or inability to maintain adequate nutrition Signs of dehydration , such as reduced urine output, dizziness, or extreme thirst Your GP will conduct a thorough assessment, which may include examination of your throat, neck, and lymph nodes
The comparison data between all three agents, semaglutide vs tirzepatide vs retatrutide , provides a framework for understanding dose-response relationships and receptor pharmacology that extends beyond any single compound
Selleck, TX, USA), diluted with sterile saline, was injected i.p
